On August 19, 2020, Cellivery Therapeutics, Inc. (KOSDAQ:A268600) closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,680 KRW | -29.91% | -.--% | -.--% |
2023 | Cellivery Therapeutics, Inc.(KOSDAQ:A268600) dropped from S&P Global BMI Index | CI |
2021 | Cellivery Therapeutics, Inc. acquired Ajin Clean Co., Ltd. from SVAJ Holdings for KRW 14.2 billion. | CI |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
133,800 KRW | +0.75% | +6.70% | 2.61B | ||
5,510 KRW | +0.36% | +4.55% | 201M | ||
1st Jan change | Capi. | |
---|---|---|
-.--% | 178M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- A268600 Stock
- News Cellivery Therapeutics, Inc.
- Cellivery Therapeutics, Inc. announced that it has received KRW 43.9988081 billion in funding from a group of investors